Global Mono Rapid Testing Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Lateral Flow Assay Kit and Agglutination Assay Kits.

By Application;

Infectious Diseases Testing, Substance Abuse Testing, and Others.

By End User;

Hospital, Clinics, Homecare Setting, Research Centers, and Diagnostics Centers.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn934408540 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Mono Rapid Testing Market (USD Million), 2021 - 2031

In the year 2024, the Global Mono Rapid Testing Market was valued at USD 558.73 million. The size of this market is expected to increase to USD 957.56 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.0%.

The Global Mono Rapid Testing Market addresses the need for rapid and accurate diagnosis of infectious mononucleosis, commonly known as mono, caused by the Epstein-Barr virus (EBV). Mono is a prevalent viral infection characterized by symptoms such as fever, sore throat, swollen lymph nodes, and fatigue. Rapid testing for mono is crucial for timely diagnosis and appropriate patient management, particularly in clinical settings such as primary care clinics, urgent care centers, and hospital emergency departments. Mono rapid tests offer the advantage of providing quick results, typically within minutes, allowing healthcare providers to promptly initiate treatment or implement infection control measures as necessary.

Mono rapid testing market growth is driven by several factors, including the increasing incidence of mono infections globally, particularly among adolescents and young adults. Mono is highly contagious and is typically transmitted through saliva, making it prevalent among individuals in close contact settings such as schools, colleges, and military barracks. Rapid testing for mono enables healthcare providers to quickly identify infected individuals and implement preventive measures to minimize disease transmission. The adoption of point-of-care testing (POCT) solutions, including mono rapid tests, is growing due to the need for efficient diagnostic tools that can deliver timely results and facilitate prompt clinical decision-making.

The global mono rapid testing market is characterized by the presence of various market players offering a range of rapid test kits based on different detection methodologies, including lateral flow immunoassays and immunochromatographic assays. These tests typically detect specific antibodies produced by the immune system in response to EBV infection, providing reliable results with high sensitivity and specificity. Market competition drives ongoing innovation in test performance, ease of use, and cost-effectiveness, ensuring that mono rapid testing remains a vital tool in the diagnostic armamentarium for healthcare providers worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Mono Rapid Testing Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Infectious Mononucleosis
        2. Point-of-Care
        3. Rapid Diagnosis
      2. Restraints
        1. Limited Sensitivity
        2. False Negatives
        3. Cross-reactivity Concerns
      3. Opportunities
        1. Point-of-care Expansion
        2. Technological Advancements
        3. Emerging Markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Mono Rapid Testing Market, By Product Type, 2021 - 2031 (USD Million)
      1. Lateral Flow Assay Kit
      2. Agglutination Assay Kits
    2. Global Mono Rapid Testing Market, By Application, 2021 - 2031 (USD Million)
      1. Infectious Diseases Testing
      2. Substance Abuse Testing
      3. Others
    3. Global Mono Rapid Testing Market, By End User, 2021 - 2031 (USD Million)
      1. Hospital
      2. Clinics
      3. Homecare Setting
      4. Research Centers
      5. Diagnostics Centers
    4. Global Mono Rapid Testing Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Cardinal Health
      2. ELITech Group
      3. Sekisui Diagnostics
      4. Thermofisher Scientific Inc.
      5. Cortez Diagnostic, Inc.
      6. Quidel Corporation
      7. Genzyme Diagnostics
      8. Jant Pharmacal Corporation
  7. Analyst Views
  8. Future Outlook of the Market